Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...

A groundbreaking study from the University of Cambridge reveals a new drug that can significantly reduce brain damage caused ...

Despite the recent buzz, the effort to reduce animal testing in favor of NAMs has been underway for years. The VQN falls ...

The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary ...

A ction has been taken to remove vehicle dwellers from near a school after evidence of drug dealing and anti-social behaviour ...

Sanofi will acquire rights to develop and commercialize the drug for $130 million upfront, with Visirna eligible for up to $265 million in milestone payments.

Certain types of lipids resist being crowded, while others can get shoved in as tight as sardines. And the packing density is ...

Kisunla, a newly approved Alzheimer's drug in Taiwan, would not be covered by the National Health Insurance (NHI) system, ...

President Donald Trump surprised pharma CEOs on Thursday with letters demanding they acquiesce to his most-favored ...

The governor of New York says she will be pushing the legislature to amend the state’s marijuana law to address a recently ...

When surgeons repair tissues, they're currently limited to mechanical solutions such as sutures and staples, which can cause their own damage, or meshes and glues that may not adequately bond with ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.